Hematopoietic Stem Cell Transplantation (HSCT) Market to Witness Upward Trend Due to High Prevalence of Certain Blood Cancers
Hematopoietic Stem Cell Transplantation (HSCT) is a specialized form of blood stem cell transplant therapy. The term hematopoietic refers to the function of the stem cells in human beings. 'Stem cell' refers to specialized stem cell types which are capable of developing into specific cells like bone, muscle, blood, and nerve cells.
Hematopoietic
stem cell transplantation can be used in the treatment of certain cancers of
the blood or bone marrow, such as multiple myeloma or leukemia. High prevalence
of such diseases is expected to aid in growth of the hematopoietic stem cell
transplantation (HSCT) market. According to Leukemia and Lymphoma Society,
176,200 people in the US are expected to be diagnosed with leukemia, lymphoma
or myeloma in 2019.
The
hematopoietic stem cell transplantation (HSCT) market in North America is
witnessing high growth, owing to high adoption of allogeneic hematopoietic stem
cell transplant. Around 30,000 patients undergo allogeneic hematopoietic stem
cell transplant annually in the United States.
Hematopoietic
cell transplantation is the transplantation of stem cells, generally derived
from bone marrow, umbilical cord, or peripheral blood. It can also be
allogenic, autologous or syngeneic. The most common type of stem cell
transplant is the allogenic transplant, which is essentially the process of
harvesting such stem cells that have the ability to develop into many different
specialized cell types, like bone, kidney, heart, liver, lungs, pancreas,
nervous, and immune cells. However, approximately 20% to 85% of the patients develop
acute Graft Versus Host Disease that affects the skin, gut, or liver. Such
scenario hinders the growth of hematopoietic stem cell transplantation (HSCT)
market.
There
are different methods of transplant. In case of a basic transplant, the stem
cells are directly transplanted into a person's veins, while a minimal invasive
procedure also known as a micro-implantation requires the injection of the
cells into the patient's veins. Based on the exact needs of the patient, the
specific type of transplant is done. For example, a child who has undergone
bone marrow transplantation can go on to have other stem cell types utilized
for the same purpose. This is one of the most commonly performed types of
transplants.
High
prevalence of sickle cell anemia is also expected to aid in growth of the hematopoietic
stem cell transplantation (HSCT) market. Specially created stem cell therapies
can be used in the treatment of sickle cell anemia. These cells are basically
taken from the bone marrow of the person and then induced to form a thick,
jelly like substance. The patient will need to take medicine for a few days
after the procedure to help his body process the cells.
Hematopoietic
cell transplantation has its own set of complications, which limit the growth
of the hematopoietic stem cell transplantation (HSCT) market. Some of these
include infection, allergic reactions, bleeding, and scarring. Infection can
occur if there is a severe immune deficiency. The patient will also have to
take antibiotics to clear up the infections. If the stem cells are used, they
have to be grown under very strict conditions to avoid rejection. Most surgeons
try to perform this transplant first on those people who suffer from serious
diseases like leukemia or cancer as these are the people who stand the best
chance to be successful.
Comments
Post a Comment